サンプル依頼リスト カート
  • English
  • Korean
表紙：ナノテクノロジーによるドラッグデリバリーの世界市場規模調査＆予測：技術別、用途別、地域別分析、2023-2030年
市場調査レポート
商品コード
1381777

ナノテクノロジーによるドラッグデリバリーの世界市場規模調査＆予測：技術別、用途別、地域別分析、2023-2030年

Global Nanotechnology Drug Delivery Market Size study & Forecast, by Technology by Application and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ナノテクノロジーによるドラッグデリバリーの世界市場規模調査＆予測：技術別、用途別、地域別分析、2023-2030年
出版日: 2023年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナノテクノロジー医薬品は、体内の特定の細胞、組織、臓器への薬剤の標的デリバリーを強化します。

これは、制御された方法で治療薬を送達するためのナノ粒子またはナノスケール材料の設計、開発、利用を含みます。ナノテクノロジーによるドラッグデリバリーは、薬物治療の有効性と安全性を向上させることで、医療に革命をもたらす可能性を秘めています。研究開発が活発な分野であり、がん、心血管障害、神経変性疾患、感染症など、さまざまな疾患に対して数多くのナノテクノロジーベースのドラッグデリバリーシステムが研究されています。ナノテクノロジーによるドラッグデリバリー市場が拡大している背景には、がんや遺伝性疾患、心血管疾患の有病率の増加、個別化された医薬品への嗜好の高まり、さらには世界中で医薬品開発活動が活発化していることなどがあります。

糖尿病、心血管疾患、がんなどの慢性疾患の有病率の上昇を主な要因として、様々な慢性疾患に対する標的デリバリーによる新薬の需要が増加しています。糖尿病は世界中でますます一般的になってきています。国際糖尿病連合（IDF）のDiabetes Atlas Tenth Edition 2021の情報によると、2021年には5億3,700万人（20歳から79歳）が糖尿病に罹患していると推定されています。同出典によると、2030年には世界で6億4,300万人が糖尿病を患い、2045年には7億8,300万人になるといわれています。糖尿病の有病率の上昇に伴い、治療や診断のための、より技術的に洗練されたドラッグデリバリーに対する需要が高まることは間違いないです。さらに、Globocan（Global Cancer Observatory）のStatistics 2020によると、2020年には世界中で新たに1,930万人のがん患者が発生します。同資料は、がんが世界的に多発していることを指摘し、2040年までに男女を問わず2,880万人が新たにがんに罹患すると予測しています。その結果、慢性疾患の罹患率の増加は、ナノテクノロジーに基づくドラッグデリバリーシステムに対する需要を刺激し、市場拡大を促進します。さらに、市場の拡大は、ナノスケール技術の開発と研究開発努力の増大によっても支援されています。例えば2022年7月、EUのHorizon 2020 B-SMARTプロジェクトは、血液-脳脊髄液関門を通過してRNAを送達する独自の技術を開発し、治療を脳に直接投与できるようにしようとしています。そのため、ナノドラッグデリバリーシステムの発展が市場拡大の原動力となっています。さらに、ナノスケール技術の新興国市場の進展と、研究開発活動への投資の増加が、市場に新たな機会を生み出しています。しかし、ナノテクノロジードラッグデリバリー技術の高コストと商業的導入のための厳しい規制が、2023～2030年の予測期間を通じて市場の成長を阻害しています。

ナノテクノロジーによるドラッグデリバリーの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、様々な疾患の有病率の上昇、主要な市場参入企業の存在、研究開発活動への投資件数の増加、同地域における臨床試験件数と創薬活動の増加、および同地域における個別化医療への需要の高まりにより、2022年の市場を独占しました。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や技術提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 ナノテクノロジーによるドラッグデリバリーの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 ナノテクノロジーによるドラッグデリバリーの世界市場力学

  • ナノテクノロジーによるドラッグデリバリー市場の影響分析（2020～2030年）
    • 市場促進要因
      • がん、遺伝性疾患、心血管疾患の有病率の増加
      • 個別化医薬品への嗜好の高まり
      • 世界の医薬品開発活動の増加
    • 市場の課題
      • ナノテクノロジーによるドラッグデリバリー技術の高コスト
      • 製品化のための厳しい規制
    • 市場機会
      • ナノスケール技術の発展
      • 研究開発投資の増加

第4章 世界のナノテクノロジーによるドラッグデリバリー市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 ナノテクノロジーによるドラッグデリバリーの世界市場：技術別

  • 市場スナップショット
  • ナノテクノロジーによるドラッグデリバリーの世界市場：技術別、実績・ポテンシャル分析
  • ナノテクノロジーによるドラッグデリバリーの世界市場：技術別、推定・予測、2020～2030年
  • ナノテクノロジーによるドラッグデリバリー市場、サブセグメント分析
    • ナノ結晶
    • ナノ粒子
    • リポソーム
    • ミセル
    • その他

第6章 ナノテクノロジーによるドラッグデリバリーの世界市場：用途別

  • 市場スナップショット
  • ナノテクノロジーによるドラッグデリバリーの世界市場：用途別、実績・ポテンシャル分析
  • ナノテクノロジーによるドラッグデリバリーの世界市場：用途別、推定・予測、2020～2030年
  • ナノテクノロジーによるドラッグデリバリー市場、サブセグメント分析
    • 神経学
    • 腫瘍学
    • 心血管／生理学
    • 抗炎症/免疫学
    • 抗感染症
    • その他の用途

第7章 ナノテクノロジーによるドラッグデリバリーの世界市場、地域分析

  • 主要国
  • 主な新興国
  • ナノテクノロジーによるドラッグデリバリー市場、地域別市場スナップショット
  • 北米
    • 米国
      • 技術別、推定・予測、2020～2030年
      • 用途別、推定・予測、2020～2030年
    • カナダ
  • 欧州のナノテクノロジーによるドラッグデリバリー市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋のナノテクノロジーによるドラッグデリバリー市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカのナノテクノロジーによるドラッグデリバリー市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東およびアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • AbbVie Inc
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
    • Aquanova AG
    • BlueWillow Biologics
    • Bristol Myers Squibb（Celgene Inc）
    • Cytimmune Sciences Inc
    • NanoCarrier Co Ltd
    • NanOlogy LLC
    • Taiwan Liposome Co
    • Merck KGaA
    • Aphios Corporation

第9章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Nanotechnology Drug Delivery Market, report scope
  • TABLE 2. Global Nanotechnology Drug Delivery Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Nanotechnology Drug Delivery Market estimates & forecasts by Technology 2020-2030 (USD Billion)
  • TABLE 4. Global Nanotechnology Drug Delivery Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Nanotechnology Drug Delivery Market
  • TABLE 70. List of primary sources, used in the study of global Nanotechnology Drug Delivery Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Nanotechnology Drug Delivery Market, research methodology
  • FIG 2. Global Nanotechnology Drug Delivery Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Nanotechnology Drug Delivery Market, key trends 2022
  • FIG 5. Global Nanotechnology Drug Delivery Market, growth prospects 2023-2030
  • FIG 6. Global Nanotechnology Drug Delivery Market, porters 5 force model
  • FIG 7. Global Nanotechnology Drug Delivery Market, pest analysis
  • FIG 8. Global Nanotechnology Drug Delivery Market, value chain analysis
  • FIG 9. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Nanotechnology Drug Delivery Market, regional snapshot 2020 & 2030
  • FIG 15. North America Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Nanotechnology drugs enhance the targeted delivery of drugs to specific cells, tissues, or organs in the body. It involves the design, development, and utilization of nanoparticles or nanoscale materials to deliver therapeutic agents in a controlled manner. Nanotechnology drug delivery has the potential to revolutionize healthcare by improving the efficacy and safety of drug treatments. It is an active area of research and development, with numerous nanotechnology-based drug delivery systems being investigated for various diseases, including cancer, cardiovascular disorders, neurodegenerative diseases, and infectious diseases. The Nanotechnology Drug Delivery market is expanding because of factors such as the growing prevalence of cancer and genetic and cardiovascular diseases and growing preference for personalized medicines as well as the rising number of drug development activities across the world.

Demand for novel drugs with targeted delivery for various chronic diseases has increased primarily due to the rising prevalence of chronic diseases such as diabetes, cardiovascular, cancer disease. Diabetes is becoming more and more common among people worldwide. According to information from the International Diabetes Federation (IDF) Diabetes Atlas Tenth Edition 2021, 537 million persons (aged 20 to 79) were estimated to have diabetes in 2021. According to the same source, by 2030 there will be 643 million individuals worldwide living with diabetes, and by 2045 there will be 783 million. The demand for more technologically sophisticated drug delivery alternatives for treatment and diagnosis will undoubtedly rise as the prevalence of diabetes rises. In addition, the Global Cancer Observatory's (Globocan) Statistics 2020 report that there were 19.3 million new cases of cancer worldwide in 2020,. The same source notes that cancer is becoming more common worldwide and predicts that by 2040, there would be 28.8 million new instances of cancer in people of both sexes. As a result, the growing incidence of chronic diseases stimulates the demand for drug delivery systems based on nanotechnology, promoting market expansion. Furthermore, the expansion of the market has also been assisted by growing developments in nanoscale technologies and research & development efforts. In July 2022, for instance, the EU Horizon 2020 B-SMART project tried to develop a unique technique for delivering RNA past the blood-cerebrospinal fluid barrier, enabling therapies to be given directly to the brain. Therefore, developments in nano drug delivery systems fuel market expansion. Moreover, increasing advancements in nanoscale technologies, and a rising number of investments in research and development activities is creating new opportunities for the market. However, the high cost of nanotechnology drug delivery techniques and stringent regulations for commercial introduction stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Nanotechnology Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to rising prevalence of various diseases, the presence of key market players, rising number of investments in research and development activities, rising number of clinical trials and drug discoveries activities in the region as well as rising demand for personalized medicine in the region.

Major market players included in this report are:

  • AbbVie Inc
  • Aquanova AG
  • BlueWillow Biologics
  • Bristol Myers Squibb (Celgene Inc)
  • Cytimmune Sciences Inc
  • NanoCarrier Co Ltd
  • NanOlogy LLC
  • Taiwan Liposome Co
  • Merck KGaA
  • Aphios Corporation

Recent Developments in the Market:

  • In June 2022, Researchers at the Baker Heart and Diabetes Institute created and developed a novel nanoparticle drug delivery system that can diagnose and treat several ailments as well as significantly increase the efficacy of a medication used to treat atherosclerosis.
  • In January 2022, Researchers at Case Western Reserve University developed nanoparticles that deliver clot-promoting enzymes to the bleeding site and then release them there to produce fibrin, the body's meshlike component that is essential for stopping the bleeding, where it is needed.

Global Nanotechnology Drug Delivery Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Technology, Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

  • Nanocrystals
  • Nanoparticles
  • Liposomes
  • Micelles
  • Others

By Application:

  • Neurology
  • Oncology
  • Cardiovascular/Physiology
  • Anti-inflammatory/Immunology
  • Anti-infective
  • Other Applications

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Nanotechnology Drug Delivery Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Nanotechnology Drug Delivery Market, by Technology, 2020-2030 (USD Billion)
    • 1.2.3. Nanotechnology Drug Delivery Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Nanotechnology Drug Delivery Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Nanotechnology Drug Delivery Market Dynamics

  • 3.1. Nanotechnology Drug Delivery Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of cancer and genetic and cardiovascular diseases
      • 3.1.1.2. Growing preference for personalized medicines
      • 3.1.1.3. Rising number of drug development activities across the world.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of nanotechnology drug delivery technique
      • 3.1.2.2. Stringent regulations for commercialization of product
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing developments in nanoscale technologies
      • 3.1.3.2. Rising investments for research and development

Chapter 4. Global Nanotechnology Drug Delivery Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Nanotechnology Drug Delivery Market, by Technology

  • 5.1. Market Snapshot
  • 5.2. Global Nanotechnology Drug Delivery Market by Technology, Performance - Potential Analysis
  • 5.3. Global Nanotechnology Drug Delivery Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
  • 5.4. Nanotechnology Drug Delivery Market, Sub Segment Analysis
    • 5.4.1. Nanocrystals
    • 5.4.2. Nanoparticles
    • 5.4.3. Liposomes
    • 5.4.4. Micelles
    • 5.4.5. Others

Chapter 6. Global Nanotechnology Drug Delivery Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Nanotechnology Drug Delivery Market by Application, Performance - Potential Analysis
  • 6.3. Global Nanotechnology Drug Delivery Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Nanotechnology Drug Delivery Market, Sub Segment Analysis
    • 6.4.1. Neurology
    • 6.4.2. Oncology
    • 6.4.3. Cardiovascular/Physiology
    • 6.4.4. Anti-inflammatory/Immunology
    • 6.4.5. Anti-infective
    • 6.4.6. Other Applications

Chapter 7. Global Nanotechnology Drug Delivery Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Nanotechnology Drug Delivery Market, Regional Market Snapshot
  • 7.4. North America Nanotechnology Drug Delivery Market
    • 7.4.1. U.S. Nanotechnology Drug Delivery Market
      • 7.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Nanotechnology Drug Delivery Market
  • 7.5. Europe Nanotechnology Drug Delivery Market Snapshot
    • 7.5.1. U.K. Nanotechnology Drug Delivery Market
    • 7.5.2. Germany Nanotechnology Drug Delivery Market
    • 7.5.3. France Nanotechnology Drug Delivery Market
    • 7.5.4. Spain Nanotechnology Drug Delivery Market
    • 7.5.5. Italy Nanotechnology Drug Delivery Market
    • 7.5.6. Rest of Europe Nanotechnology Drug Delivery Market
  • 7.6. Asia-Pacific Nanotechnology Drug Delivery Market Snapshot
    • 7.6.1. China Nanotechnology Drug Delivery Market
    • 7.6.2. India Nanotechnology Drug Delivery Market
    • 7.6.3. Japan Nanotechnology Drug Delivery Market
    • 7.6.4. Australia Nanotechnology Drug Delivery Market
    • 7.6.5. South Korea Nanotechnology Drug Delivery Market
    • 7.6.6. Rest of Asia Pacific Nanotechnology Drug Delivery Market
  • 7.7. Latin America Nanotechnology Drug Delivery Market Snapshot
    • 7.7.1. Brazil Nanotechnology Drug Delivery Market
    • 7.7.2. Mexico Nanotechnology Drug Delivery Market
  • 7.8. Middle East & Africa Nanotechnology Drug Delivery Market
    • 7.8.1. Saudi Arabia Nanotechnology Drug Delivery Market
    • 7.8.2. South Africa Nanotechnology Drug Delivery Market
    • 7.8.3. Rest of Middle East & Africa Nanotechnology Drug Delivery Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. AbbVie Inc
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Aquanova AG
    • 8.3.3. BlueWillow Biologics
    • 8.3.4. Bristol Myers Squibb (Celgene Inc)
    • 8.3.5. Cytimmune Sciences Inc
    • 8.3.6. NanoCarrier Co Ltd
    • 8.3.7. NanOlogy LLC
    • 8.3.8. Taiwan Liposome Co
    • 8.3.9. Merck KGaA
    • 8.3.10. Aphios Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption